Claude discovers new CRISPR-like system in bacteriophages

Summary

Anthropic's Claude agents scanned over 200,000 reverse transcriptases and flagged a previously unrecognized CRISPR-like system (ART) in bacteriophages. This system pairs a known reverse transcriptase with a tandem repeat sequence and a yet-uncharacterized partner protein.

Why it matters

This serves as concrete evidence that AI agents can perform hypothesis-generating genome mining on a large scale and in a fraction of the time it would take human experts. This has the potential to accelerate the discovery of new biological mechanisms. If ART is validated as a functional and programmable editing system, it will expand the molecular toolkit beyond CRISPR-Cas. However, the finding is at a very early, unverified stage, with its biological role yet to be proven.

Highlights

• Approximately 950 Claude agents consumed around 210 million tokens over 21 hours to narrow down over 200,000 enzymes to 20 detailed candidates.
• The ART repeat sequence is transcribed into multiple short RNAs. This feature mirrors how CRISPR arrays produce guide RNAs.
• The reverse transcriptase itself had already been cataloged in a giant phage. The novelty lies in the surrounding repeat sequence and an unknown helper protein.

Critical take

The term 'CRISPR-like' in the headline overstates a system whose function is completely unknown and which has not demonstrated the ability to cut, copy, or insert DNA, according to Anthropic's own admission. The core enzyme was already present in the literature. Therefore, it is premature to label this as the 'discovery of a new gene-editing mechanism' until wet-lab validation confirms programmable activity.